1 Min Read
* LEAP THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND ANNOUNCES DATE OF ITS ANNUAL MEETING OF STOCKHOLDERS
* LEAP THERAPEUTICS - QTRLY LOSS PER SHARE $0.65 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.